Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects.

de Courten B, Moreno-Navarrete JM, Lyons J, Soldatos G, de Courten M, Dougherty S, Forbes J, Fernández-Real JM.

Mol Nutr Food Res. 2015 Jun 26. doi: 10.1002/mnfr.201500102. [Epub ahead of print]

PMID:
26114238
2.

The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit.

Bach LA, Ekinci EI, Engler D, Gilfillan C, Hamblin PS, MacIsaac RJ, Soldatos G, Steele C, Ward GM, Wyatt S.

Med J Aust. 2014 Sep 15;201(6):334-8.

PMID:
25222457
3.

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects.

Forbes JM, Sourris KC, de Courten MP, Dougherty SL, Chand V, Lyons JG, Bertovic D, Coughlan MT, Schlaich MP, Soldatos G, Cooper ME, Straznicky NE, Kingwell BA, de Courten B.

Amino Acids. 2014 Feb;46(2):321-6. doi: 10.1007/s00726-013-1542-9. Epub 2013 Jul 6.

PMID:
23832534
4.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

5.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

6.

Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes.

Soldatos G, Jandeleit-Dahm K, Thomson H, Formosa M, D'orsa K, Calkin AC, Cooper ME, Ahimastos AA, Kingwell BA.

Diabet Med. 2011 Jan;28(1):54-60. doi: 10.1111/j.1464-5491.2010.03146.x.

PMID:
21166846
7.

Does intensive glycemic control for type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk?

Soldatos G, Cooper ME.

Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):138-9. doi: 10.1038/ncpendmet1076. Epub 2009 Feb 3.

PMID:
19190588
8.

Diabetic nephropathy: important pathophysiologic mechanisms.

Soldatos G, Cooper ME.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S75-9. doi: 10.1016/j.diabres.2008.09.042. Review.

PMID:
18994672
9.

Advanced glycation end products and vascular structure and function.

Soldatos G, Cooper ME.

Curr Hypertens Rep. 2006 Dec;8(6):472-8. Review.

PMID:
17087858
11.

Advanced-glycation end products in insulin-resistant states.

Soldatos G, Cooper ME, Jandeleit-Dahm KA.

Curr Hypertens Rep. 2005 Apr;7(2):96-102. Review.

PMID:
15748532
12.

Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction.

Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J.

Intern Med J. 2005 Jan;35(1):67-8. No abstract available.

PMID:
15667475
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk